Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 26, 2024

BUY
$0.29 - $0.53 $4,077 - $7,452
14,062 New
14,062 $4,000
Q1 2023

May 01, 2023

SELL
$0.87 - $1.36 $39,139 - $61,183
-44,988 Reduced 58.07%
32,481 $34,000
Q4 2022

Feb 15, 2023

BUY
$0.82 - $1.03 $7,566 - $9,503
9,227 Added 13.52%
77,469 $64,000
Q3 2022

Nov 07, 2022

BUY
$1.04 - $1.27 $16,039 - $19,587
15,423 Added 29.2%
68,242 $68,000
Q2 2022

Aug 09, 2022

BUY
$0.94 - $1.76 $49,649 - $92,961
52,819 New
52,819 $65,000
Q4 2021

Feb 17, 2022

SELL
$1.42 - $2.13 $132,748 - $199,123
-93,485 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$1.42 - $2.0 $132,748 - $186,970
93,485 New
93,485 $156,000
Q2 2021

Sep 17, 2021

SELL
$1.21 - $1.89 $181,007 - $282,730
-149,593 Closed
0 $0
Q1 2021

May 19, 2021

BUY
$1.31 - $3.0 $165,793 - $379,680
126,560 Added 549.47%
149,593 $253,000
Q4 2020

Feb 24, 2021

BUY
$0.96 - $1.51 $3,616 - $5,688
3,767 Added 19.55%
23,033 $31,000
Q3 2020

Dec 11, 2020

SELL
$0.98 - $1.52 $21,612 - $33,522
-22,054 Reduced 53.37%
19,266 $19,000
Q2 2020

Aug 07, 2020

SELL
$0.84 - $1.11 $7,352 - $9,715
-8,753 Reduced 17.48%
41,320 $41,000
Q4 2019

Feb 04, 2020

BUY
$0.72 - $0.9 $36,052 - $45,065
50,073 New
50,073 $41,000
Q3 2019

Nov 20, 2019

SELL
$0.74 - $0.87 $14,081 - $16,555
-19,029 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$0.79 - $1.66 $15,032 - $31,588
19,029 New
19,029 $16,000
Q1 2019

Apr 12, 2019

SELL
$0.73 - $2.1 $15,620 - $44,935
-21,398 Closed
0 $0
Q4 2018

Jan 16, 2019

SELL
$0.63 - $1.12 $3,833 - $6,815
-6,085 Reduced 22.14%
21,398 $15,000
Q3 2018

Nov 13, 2018

BUY
$0.92 - $1.43 $25,284 - $39,300
27,483 New
27,483 $27,000
Q2 2018

Jul 30, 2018

SELL
$0.76 - $1.48 $55,942 - $108,941
-73,609 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$0.76 - $1.48 $25,843 - $50,325
34,004 Added 85.86%
73,609 $86,000
Q1 2018

May 14, 2018

BUY
$0.83 - $2.79 $32,872 - $110,497
39,605 New
39,605 $33,000

Others Institutions Holding DARE

About Dare Bioscience, Inc.


  • Ticker DARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,820,896
  • Market Cap $28.8M
  • Description
  • Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...
More about DARE
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.